the "blue chip" in the biotech sector

People are forgetting about the incredible recent developments in Novogen. When NRT make their next "big" announcement the stock will rally hard (if the development is positive that is!!).

"Animals received cisplatin (0.5mg/kg), or phenoxodiol at 10 or 20 mg/kg for eight days alone or in combination with cisplatin (0.5 mg/kg). While cisplatin alone had no effect on tumor size, the combination of phenoxodiol (10mg/kg) and cisplatin (0.5mg/kg) reduced tumor mass by 75 percent."

This holds true for the current ovarian cancer trial which Dr Rutherford already stated they are seeing "regression or stabilisation...".

The more and more boomish the sector gets the more and more Novogen will rally when positive developments are announced.

Keep this on the watch list.